Position in JNJ
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,560,899
+$68,349 QoQ
Shares Held
6,146
+0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.91%
of 13F equity value
Holder Rank
#2,566
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Nadler Financial Group, Inc. holds $7,548,194 across 7 Drug Manufacturers - General names. JNJ ranks #3 (20.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,767 | $2,119,392 | |
| 2 | ABBV |
AbbVie Inc.
|
7,729 | $1,944,925 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
6,146 | $1,560,899 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,005 | $771,642 | |
| 5 | AMGN |
Amgen Inc
|
1,389 | $502,984 | |
| 6 | PFE |
Pfizer Inc
|
15,802 | $380,512 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,120 | $267,840 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,560,899 | 6,146 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,492,550 | 6,106 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,263,429 | 6,105 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $1,108,626 | 5,979 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $884,269 | 5,789 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $960,047 | 5,789 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $837,205 | 5,789 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $841,577 | 5,193 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $775,378 | 5,305 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $854,700 | 5,403 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $793,888 | 5,065 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $788,873 | 5,065 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $821,806 | 4,965 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $829,560 | 5,352 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $951,613 | 5,387 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $877,569 | 5,372 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $921,631 | 5,192 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $902,455 | 5,092 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,002,641 | 5,861 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $989,995 | 6,130 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $974,766 | 5,917 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $980,347 | 5,965 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $934,837 | 5,940 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $903,999 | 6,072 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $830,560 | 5,906 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $767,372 | 5,852 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||